Harvard Bioscience Inc (HBIO) earnings · rev $86.5M
These earnings events as JSON? API free 100/dayHarvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
This HBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.
When the next HBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 8.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full HBIO research stays on the stock page; the tape stays on the quote page.
HBIO earnings FAQ
What are HBIO's latest revenue and net income?
Latest cached Harvard Bioscience Inc (HBIO) revenue for Dec 31, 2025 was $86.5M. Net income was -$56.7M. Statements: https://lician.com/financials/hbio
What is HBIO's latest diluted EPS?
Latest cached Harvard Bioscience Inc (HBIO) diluted EPS for Dec 31, 2025 was -$1.28.
What period does the latest HBIO earnings print cover?
The latest cached Harvard Bioscience Inc (HBIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did HBIO revenue change from the prior cached period?
Cached Harvard Bioscience Inc (HBIO) revenue was down 8.1% from $94.1M (Dec 31, 2024) to $86.5M (Dec 31, 2025). Statements: https://lician.com/financials/hbio
Where are HBIO earnings listed?
Cached earnings facts for Harvard Bioscience Inc (HBIO) are listed at https://lician.com/earnings/hbio. Statements: https://lician.com/financials/hbio
Not investment advice.